We learn from mother nature on how to forge the components of drugs having no side effects
Understanding language of life
Already in 2012, The National Academy of Sciences wrote that glycans are involved in every major disease.
Glycans are increasingly important in pharmaceutical developments, ranging from adjuvants in antibiotics therapy, to a regenerative cure against arthritis, to a means to treat specific cancers or metabolic diseases.
Inbiose is capable of producing an ever-increasing range of specialty glycans and derivatives, applying synthesis and purification techniques that can be utilized into large scale manufacturing.
Inbiose competences include the application of ‘–omics’ technologies, we make use of artificial intelligence and employ the best in class enzyme-modelling engineers to enable accurate glycan and glycoconjugate structural prediction.